Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to compare changes in spinal stiffness and back muscle activity between spinal manipulative therapy (SMT) responders, non-responders and asymptomatic participants. Additionally, the investigators wanted to compare the amount of lumbar degeneration between SMT responders, non-responders and asymptomatic participants. This study also determines if the presence of pain modifies post-SMT spinal stiffness and back muscle activity.
SMT is a common manual therapy for treating patients with mechanical low back pain (LBP). SMT is defined as a high velocity, low amplitude thrust technique. Specifically, the clinician stands beside a supine patient. The patient is passively side-bent towards the side to be manipulated. The clinician passively rotates the patient and then delivers a high velocity, low amplitude thrust to the anterior superior iliac spine in a posteroinferior direction. SMT is indicated for patients with LBP judged to have spinal hypomobility or malalignment. Recently, our collaborators have discovered that LBP subjects who benefit from SMT can be identified prior to treatment by a five-item clinical prediction rule. Compared to non-responders, those who respond to SMT have: 1) more than 30% decrease in the modified Oswestry Disability Index score, 2) a significant and immediate decrease in spinal stiffness, and 3) a concurrent change in lumbar multifidus muscle activity. Taken together, the physical changes experienced by SMT responders alone provide an unique opportunity to better understand the mechanisms underlying SMT.
Since spinal stiffness is an important physical indicator of SMT response, it is important to understand the causal relation between pain, paraspinal/trunk muscle activity and spinal stiffness. Although research has shown positive correlation between pain and muscle activity, and between paraspinal muscle activity and spinal stiffness, the causal relation between pain, paraspinal/trunk muscle activity and spinal stiffness remains unknown. Given this background, an induction of temporary benign experimental pain to asymptomatic individuals can help clarify such causal relation and improve our understanding of physical responses in responders following pain resolution by SMT.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| SMT for low back pain patients | Experimental | To investigate the effects of high velocity, low amplitude lumbopelvic spinal manipulative therapy on spinal stiffness and back muscle activity. |
|
| Asymptomatic arm | Other | To investigate the sequential changes in spinal stiffness and back muscle activity of asymptomatic participants over time without any intervention. Participants of this arm can volunteer for an additional experimental pain protocol after their third visit (at 1 week) to investigate the effects of experimental pain on the changes of spinal stiffness and back muscle activity using a randomized crossover design (injecting 5% hypertonic saline or 0.9% isotonic saline to the interspinous ligaments at L3 to L5 levels in random order in two additional visits). |
|
| Low back pain participants without SMT | Other | To investigate the temporal changes in lumbar disc diffusion within a 1-hour period without SMT |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| SMT for low back pain patients | Other | High velocity, low amplitude spinal manipulative therapy (HVLA-SMT) will be provided to the lumbopelvic region on both sides. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change of Modified Oswestry Low Back Pain Disability Index | It is a questionnaire to assess the participants' perceived low back pain related functional disability. | baseline, Day 3, and 1 week |
| Change of 11-point Numeric Pain Rating Scale | It is a scale to measure the perceived pain intensity by the participants. | baseline, Day 3, and 1 week |
| Change in Body Pain diagram | The diagram will be used to demarcate the location and area of symptoms | Baseline, Day 3, and 1 week |
| Measure | Description | Time Frame |
|---|---|---|
| Change in measurement of lumbar multifidus muscle thickness by rehabilitative ultrasound imaging | Using the rehabilitative ultrasound imaging to measure lumbar multifidus muscle thickness at rest and during an automatic muscle contraction. | Baseline, Day 3, and 1 week |
| Change of spinal stiffness testing by a mechanical indentation machine |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of lumbar multifidus muscle thickness by rehabilitative ultrasound imaging in the pain induction experiment | Using the rehabilitative ultrasound imaging to measure lumbar multifidus muscle thickness at rest and during an automatic muscle contraction. | Before the injection, immediately after the injection, and 25-minute after the injection in each session |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gregory N Kawchuk, PhD, DC | Department of Physical Therapy, Faculty of Rehabilitation Medicine, University of Alberta | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| River Valley Health Clinic | Edmonton | Alberta | T6G 2C8 | Canada |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Pain induction (optional) | Other | A randomized crossover design is used to investigate the changes in spinal stiffness and back muscle activity of asymptomatic participants following an experimental pain induction procedure. Specifically, asymptomatic participants attend two separate sessions 5 days apart. Participants will receive 0.3 ml of 5% hypertonic saline or 0.9% isotonic saline in random order into the interspinous ligaments at L3 to L5 levels. The resulting temporal changes in pain intensity, spinal stiffness and trunk muscle activity following saline injections will be monitored. During the second session, the participants will undergo the same procedures but with the previously unused saline concentration. |
|
| Low back pain participants without SMT | Other | No treatment |
|
The spinal stiffness of participants will be measured by a validated mechanical indentation machine. Briefly, a 60 N load will be applied to the third lumbar spinous process and the corresponding spinal tissue deformations will be measured. The spinal stiffness will be calculated from the force-displacement curve of each indentation. |
| Baseline, Day 3, and 1 week |
| Electromyography of trunk muscles | Electromyography of abdominal and erector spinae muscles during spinal stiffness testing will be measured. | At the third visit (1 week from the baseline) |
| Magnetic resonance imaging of lumbar region for participants with low back pain | It records the anatomical features of the lumbar spine and the changes in lumbar disc diffusion during the first session (an expected average of 1-hour duration). | At the beginning and immediately after the first visit (an expected average of 1 hour apart) |
| Fear Avoidance Beliefs Questionnaire | It assesses the fear avoidance behaviour of participants | Baseline |
| Change in Borg Category-Ratio Scale of Perceived Exertion | It measures the subjective perception of exertion during the spinal stiffness test and muscle testings | Baseline, Day 3, and 1 week |
| Global Rating Of Change | It measures the perceived change of body function from the first visit. | 1 week after baseline |
| Spinal stiffness assessment by mechanical indentation machine in the pain induction experiment | The spinal stiffness of participants will be measured by a validated mechanical indentation machine. Briefly, a 60 N load will be applied to the third lumbar spinous process and the corresponding spinal tissue deformations will be measured. The spinal stiffness will be calculated from the force-displacement curve of each indentation. | Before the injection, immediately after the injection, and 25-minute after the injection in each session |
| Electromyography of trunk muscles in the pain induction experiment | Electromyography of abdominal and erector spinae muscles during spinal stiffness testing will be measured. | Before the injection, immediately after the injection, and 25-minute after the injection in each session |
| 11-point Numeric Pain Rating Scale in the pain induction experiment | It is a scale to measure the perceived pain intensity by the participants. | Before the injection, immediately after the injection, and 25-minute after the injection in each session |
| Body Pain diagram in the pain induction experiment | The diagram will be used to demarcate the location and area of symptoms | Before the injection, immediately after the injection, and 25-minute after the injection in each session |
| Modified Oswestry low back pain disability index in the pain induction experiment | It is a questionnaire to assess the participants' perceived low back pain related functional disability. | Before the injection in each session |
| Fear of Pain Questionnaire - III in the pain induction experiment | It measures the perceived fear of pain under different hypothetical painful experiences. | Before the injection in the first session |
| Fear Avoidance Beliefs Questionnaire in the pain induction experiment | It assesses the fear avoidance behaviour of participants | Before the injection in the first session |
| Borg Category-Ratio Scale of Perceived Exertion in the pain induction experiment | It measures the subjective perception of exertion during the spinal stiffness test and muscle testings | Before the injection, immediately after the injection, and 25-minute after the injection in each session |
| ID | Term |
|---|---|
| D017116 | Low Back Pain |
| D018908 | Muscle Weakness |
| ID | Term |
|---|---|
| D001416 | Back Pain |
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D009135 | Muscular Diseases |
| D009140 | Musculoskeletal Diseases |
| D020879 | Neuromuscular Manifestations |
| D009422 | Nervous System Diseases |
| D010335 | Pathologic Processes |
Not provided
Not provided
| ID | Term |
|---|---|
| D020393 | Manipulation, Spinal |
| ID | Term |
|---|---|
| D026201 | Musculoskeletal Manipulations |
| D026741 | Physical Therapy Modalities |
| D013812 | Therapeutics |
| D012046 | Rehabilitation |
Not provided
Not provided